We are live on ! Find out more
AFC

Ares Financial Consulting Portfolio holdings

AUM $139M
This Fund
S&P 500
This Quarter Est. Return
+12.94%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$139M
AUM Growth
+$12.1M
Cap. Flow
+$897K
Cap. Flow %
0.64%
Top 10 Hldgs %
40.89%
Holding
1,171
New
105
Increased
235
Reduced
84
Closed
39
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PNC icon
701
PNC Financial Services
PNC
$101B
$5.2K ﹤0.01%
21
TEVA icon
702
Teva Pharmaceuticals
TEVA
$40.6B
$5.18K ﹤0.01%
153
-60
-28% -$2K
CCJ icon
703
Cameco
CCJ
$40.8B
$5.17K ﹤0.01%
51
NTNX icon
704
Nutanix
NTNX
$16.3B
$5.15K ﹤0.01%
101
ALLE icon
705
Allegion
ALLE
$14.3B
$5.06K ﹤0.01%
36
VLTO icon
706
Veralto
VLTO
$23.9B
$5.05K ﹤0.01%
57
WTW icon
707
Willis Towers Watson
WTW
$31.6B
$5.04K ﹤0.01%
19
XYZ
708
Block Inc
XYZ
$47B
$5.02K ﹤0.01%
66
+1
+2% +$70
TFLO icon
709
iShares Treasury Floating Rate Bond ETF
TFLO
$6.64B
$5.01K ﹤0.01%
99
-1,686
-94% -$85.2K
NDAQ icon
710
Nasdaq
NDAQ
$52.9B
$4.97K ﹤0.01%
63
SIRI icon
711
SiriusXM
SIRI
$10.1B
$4.96K ﹤0.01%
168
BAX icon
712
Baxter International
BAX
$14B
$4.95K ﹤0.01%
232
+205
+759% +$3.82K
NBIX icon
713
Neurocrine Biosciences
NBIX
$16.2B
$4.89K ﹤0.01%
29
+5
+21% +$742
DOC icon
714
Healthpeak Properties
DOC
$14.5B
$4.88K ﹤0.01%
228
SOUN icon
715
SoundHound AI
SOUN
$3.08B
$4.85K ﹤0.01%
750
-933
-55% -$7.22K
ZION icon
716
Zions Bancorporation
ZION
$10.3B
$4.84K ﹤0.01%
70
DLTR icon
717
Dollar Tree
DLTR
$24.9B
$4.84K ﹤0.01%
40
AES icon
718
AES
AES
$10.5B
$4.82K ﹤0.01%
329
LH icon
719
Labcorp
LH
$25.6B
$4.76K ﹤0.01%
17
+11
+183% +$2.89K
MTB icon
720
M&T Bank
MTB
$36.1B
$4.76K ﹤0.01%
20
+16
+400% +$3.5K
UGI icon
721
UGI
UGI
$7.35B
$4.73K ﹤0.01%
137
BAM icon
722
Brookfield Asset Management
BAM
$84.9B
$4.71K ﹤0.01%
105
WTS icon
723
Watts Water Technologies
WTS
$12.6B
$4.7K ﹤0.01%
12
IDA icon
724
Idacorp
IDA
$8.15B
$4.69K ﹤0.01%
31
THC icon
725
Tenet Healthcare
THC
$20.7B
$4.68K ﹤0.01%
25

Similar funds

Ares Financial Consulting's Q2 2026 Portfolio in Review

As of Q2 2026, Ares Financial Consulting held 1,171 positions worth $139M, up 9.5% from $127M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Ares Financial Consulting's Q2 2026 filing shows 105 new, 235 increased, 84 reduced and 39 closed positions. Its largest new stake was AstraZeneca: 486 shares worth $92.2K. The largest sale was Dimensional US Core Equity Market ETF, an estimated $443K.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 10% a quarter earlier, followed by Communication Services and Industrials.

  • Ares Financial Consulting's largest Q2 2026 buy was AstraZeneca: 486 shares worth $92.2K.
  • Ares Financial Consulting added most to PIMCO 15+ Year US TIPS Index Exchange-Traded Fund in Q2 2026, an estimated $567K increase.
  • Ares Financial Consulting's biggest Q2 2026 reduction was Dimensional US Core Equity Market ETF, cutting an estimated $443K.
  • Ares Financial Consulting fully exited Vanguard FTSE All-World ex-US ETF in Q2 2026, selling an estimated $203K.
  • Ares Financial Consulting's ten largest holdings make up 41% of its $139M portfolio in Q2 2026.
  • Ares Financial Consulting opened 105 new positions and closed 39 in Q2 2026.
  • Ares Financial Consulting's portfolio value rose 9.5% quarter-over-quarter to $139M.

Based on Ares Financial Consulting's 13F filing for Q2 2026, filed 9 Jul 2026.